- Home
- RNA vs TFSL Comparison
RNA vs TFSL Comparison
Compare RNA & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNA | TFSL |
|---|---|---|
| Founded | 2012 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.9B |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | RNA | TFSL |
|---|---|---|
| Price | $71.58 | $14.02 |
| Analyst Decision | Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $69.26 | N/A |
| AVG Volume (30 Days) | ★ 3.7M | 472.5K |
| Earning Date | 11-10-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 8.05% |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ 0.32 |
| Revenue | $20,868,000.00 | ★ $318,974,000.00 |
| Revenue This Year | N/A | $10.29 |
| Revenue Next Year | $108.97 | $3.28 |
| P/E Ratio | ★ N/A | $43.84 |
| Revenue Growth | ★ 106.27 | 4.70 |
| 52 Week Low | $21.51 | $11.29 |
| 52 Week High | $71.78 | $14.73 |
Technical Indicators
Market Signals| Indicator | RNA | TFSL |
|---|---|---|
| Relative Strength Index (RSI) | 77.70 | 53.47 |
| Support Level | $70.42 | $13.21 |
| Resistance Level | $71.78 | $14.49 |
| Average True Range (ATR) | 0.45 | 0.28 |
| MACD | -0.77 | 0.04 |
| Stochastic Oscillator | 85.66 | 52.48 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.